ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Zynex Inc

Zynex Inc (ZYXI)

10.22
0.09
(0.89%)
Closed July 23 4:00PM
10.22
0.00
( 0.00% )
Pre Market: 7:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
10.22
Bid
8.57
Ask
10.62
Volume
-
0.00 Day's Range 0.00
6.88 52 Week Range 13.77
Market Cap
Previous Close
10.22
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
126,649
Shares Outstanding
31,775,183
Dividend Yield
-
PE Ratio
33.37
Earnings Per Share (EPS)
0.31
Revenue
184.32M
Net Profit
9.73M

About Zynex Inc

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets me... Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others. Show more

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Website
Headquarters
Carson City, Nevada, USA
Founded
1970
Zynex Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker ZYXI. The last closing price for Zynex was $10.22. Over the last year, Zynex shares have traded in a share price range of $ 6.88 to $ 13.77.

Zynex currently has 31,775,183 shares outstanding. The market capitalization of Zynex is $324.74 million. Zynex has a price to earnings ratio (PE ratio) of 33.37.

ZYXI Latest News

Zynex Sets Second Quarter 2024 Earnings Call

Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo., July 17, 2024 ENGLEWOOD, Colo., July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical...

Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces

Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo., July 11, 2024 ENGLEWOOD, Colo., July 11, 2024 /PRNewswire/...

Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024

Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 PR Newswire ENGLEWOOD, Colo., June 10, 2024 ENGLEWOOD, Colo., June 10, 2024 /PRNewswire/ -- Zynex, Inc...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.242.404809619249.9810.629.5614631910.23070436CS
41.6218.83720930238.610.628.521292009.49514489CS
12-0.84-7.5949367088611.0612.18968.521266499.81808246CS
26-0.8-7.2595281306711.0213.778.5217112311.41523097CS
521.0411.32897603499.1813.776.882750709.55734629CS
156-6.67-39.490822972216.8917.894.972974239.84809133CS
2602.2127.59051186028.0129.72714.9740719613.5403558CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRMADermata Therapeutics Inc
$ 3.23
(148.46%)
11.86M
NUZENuZee Inc
$ 2.03
(97.09%)
7.33M
PIRSPieris Pharmaceuticals Inc
$ 14.19
(77.82%)
391.3k
BBLGBone Biologics Corporation
$ 1.90
(52.00%)
3.62M
HOTHHoth Therapeutics Inc
$ 1.39
(43.01%)
11.48M
VWEVintage Wine Estates Inc
$ 0.073
(-34.76%)
954.21k
CONNConns Inc
$ 0.3316
(-34.60%)
182.94k
SAGESage Therapeutics Inc
$ 9.60
(-26.61%)
11k
TCBPTC BioPharm Holdings PLC
$ 0.60
(-25.00%)
502
VSTMVerastem Inc
$ 2.70
(-24.79%)
84.92k
ALLRAllarity Therapeutics Inc
$ 0.207
(24.32%)
30.41M
DRMADermata Therapeutics Inc
$ 3.23
(148.46%)
11.86M
HOTHHoth Therapeutics Inc
$ 1.39
(43.01%)
11.48M
SLNASelina Hospitality PLC
$ 0.0296
(13.85%)
10.56M
NUZENuZee Inc
$ 2.03
(97.09%)
7.33M

ZYXI Discussion

View Posts
penn33c penn33c 6 months ago
Closed at 11.76 looking great
👍️0
penn33c penn33c 9 months ago
What just another GREAT Quarter And they keep reducing the amount of shares out there with there buy back program
👍️0
penn33c penn33c 10 months ago
One of the best things you could do The shorts cant short if there are no shares out there
👍️0
BobbyAx3lrod BobbyAx3lrod 10 months ago
Is that a good thing?
👍️0
penn33c penn33c 10 months ago
They are buying back another 10 million dollars worth that will make 50 million dollars in buybacks in 2 years
👍️0
BobbyAx3lrod BobbyAx3lrod 11 months ago
Same thing i said. Idk whats going on.
👍️0
BobbyAx3lrod BobbyAx3lrod 11 months ago
Wtf is going on with this company man seriously?

In 1 month, -16.57% in losses. Something is up. Is it the CEO Thomas Sandgaard leadership? Please someone make it make sense!
👍️0
Harry Wickey Harry Wickey 12 months ago
WTF
👍️0
penn33c penn33c 1 year ago
Its an obvious scenario Trading at less than 2X revenue
👍️0
penn33c penn33c 1 year ago
On a rumor? Ha Ha
👍️0
sarbel sarbel 1 year ago
What's your source?
👍️0
penn33c penn33c 1 year ago
I keep hearing there going private!!! Have you gotten any info on this?
👍️0
Twinsoul Twinsoul 1 year ago
My first purchase was apx 20 years ago too. Quite a ride...
Good luck!
Unbelievable it is as cheap as it is right now.
👍️0
penn33c penn33c 1 year ago
I think i have owned some for 20 years or longer(don't quote me on time) I have bought as low as 10 cents Fun to watch Enjoy the ride
👍️0
Twinsoul Twinsoul 1 year ago
We will, IMHO
Great company, great future.
Buy now and smile later
👍️0
penn33c penn33c 1 year ago
How can we have these prices We should be like a 40 dollar stock as we speak
👍️0
Triple nickle Triple nickle 1 year ago
To 10.78 a share
👍️0
penn33c penn33c 1 year ago
Is anyone hearing rumors that Zynex is going private?
👍️0
penn33c penn33c 1 year ago
news is out
👍️0
penn33c penn33c 1 year ago
Year end numbers come out after hours!! Good luck to everyone
👍️0
penn33c penn33c 2 years ago
Merry Christmas does anyone think we will get a rally towards the end of the year?
👍️0
penn33c penn33c 2 years ago
i Like the 13.85 but I believe we still go higher from here Anyone heard anything on the blood volume monitor?
👍️0
penn33c penn33c 2 years ago
It looks like we are going to break out from here (hello naked shorts) This might be fun
👍️0
penn33c penn33c 2 years ago
If the naked shorts have to cover there bets it could get good REAL SOON
👍️0
rado rado 2 years ago
The bottom line is finally growing. And I think the market likes the fact that there is blood monitor showing momentum.
👍️0
rado rado 2 years ago
Zynex Announces Additional Share Buyback Program

ENGLEWOOD, Colo., Nov. 1, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the Company's common stock. The program will commence on November 1, 2022 and is scheduled to terminate on October 31, 2023 or when the $10.0 million buyback limit is reached.

Zynex
Zynex
"We are committed to driving long-term value for our shareholders and believe that the current strength of our balance sheet presents a strategic opportunity for a third buyback program," said Thomas Sandgaard, founder, and CEO of Zynex. "We've repurchased $20 million of our common stock thus far in 2022 and an additional $10 million share buyback reiterates our commitment to creating value. We believe our consistent performance and ability to maintain profitability is not reflected in Zynex's market valuation and are initiating this buyback program as an attractive opportunity to deploy capital and return value to our shareholders."

Under the share buyback program, buybacks may be made from time-to-time in open market and negotiated purchases, effective immediately through the next twelve months. These buybacks will be made in compliance with the SEC's Rule 10b-18, subject to market conditions, available liquidity, cash flow, applicable legal requirements, and other factors. The specific prices, numbers of shares, and timing of purchase transactions will be determined by the Company from time to time in its sole discretion. This program does not obligate the Company to acquire any particular amount of common stock, and the program may be suspended or discontinued at any time, including in the event the Company would be deemed to be making an acquisition of its own shares under Rule 13e-3 of the Securities Exchange Act of 1934, as amended.

The Company expects to finance the purchases with existing cash balances, which is not expected to have a material impact on capital levels.

Zynex, Inc. had approximately 41.6 million shares issued and 37.5 million shares outstanding as of November 1, 2022.
👍️0
rado rado 2 years ago
Market likes the latest report.
👍️0
penn33c penn33c 2 years ago
Maybe shorts are getting nervous !!!!
👍️0
rado rado 2 years ago
ZYXI 9.73

I'm guessing the recent strength may be due to expectations over the new blood volume monitor.
👍️0
rado rado 2 years ago
9.31 +7% Nice move

Yahoo shows forward of 20.66

Which is kind of ridiculous. That net income will go down.
👍️0
rado rado 2 years ago
I'm not sure what the forward PE is. How are you getting 8?
👍️0
rado rado 2 years ago
Zynex Rev up 18% Net Income up 19%

ENGLEWOOD, Colo., July 28, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the second quarter ended June 30, 2022.

Second Quarter 2022 Highlights:

Revenue increased 18% year over year to $36.8 million

Net income increased 19% to $3.3 million; Diluted EPS of $0.08

Adjusted EBITDA increased 16% to $5.5 million

Completed initial $10 million share buyback and announced an additional program of $10 million

Recorded highest number of orders in Company history



Second Quarter 2022 Financial Results Summary:

For the second quarter, the Company reported net revenue of $36.8 million, an 18% increase over second quarter of 2021. Gross margins were 80% and net income was $3.3 million, a 19% increase from Q2 2021.

As of June 30, 2022, the Company had working capital of $51.8 million. Cash on hand was $26.9 million at the end of the second quarter.

President and CEO Commentary:

"In Q2, we posted another quarter of top line growth and increased profitability. Our reps are becoming highly efficient and revenue projections reflect our confidence in the sales force to produce exceptional results. The record orders we posted in second quarter will put us in a position to realize strong results in the second half of 2022," said Thomas Sandgaard, President and CEO. "Additionally, we completed an initial $10 million share buyback program and announced another $10 million program to signal our ability to drive shareholder value."

Third Quarter and Full Year 2022 Guidance:

Zynex is reaffirming its full year 2022 revenue estimates in the range of $150-$170 million and Adjusted EBITDA between $25-$35 million.

The estimated range for third quarter 2022 revenue is between $40-$43 million, an increase of approximately 20% from Q3 2021. Adjusted EBITDA for the third quarter 2022 is estimated to range between $7-$9 million.

Conference Call and Webcast Details:

Thursday, July 28, 2022 at 2:15 p.m. MT / 4:15 p.m. ET

To register and participate in the webcast, interested parties should click on the following link or dial in approximately 10-15 minutes prior to the webcast: https://app.webinar.net/mV4arKMJQLl

US Participant Dial In (TOLL FREE): 1-844-825-9790
International Participant Dial In: 1-412-317-5170
Canada Participant Dial In (TOLL FREE): 1-855-669-9657
👍️0
penn33c penn33c 2 years ago
Whats the forward P/E like 8?
👍️0
rado rado 2 years ago
ZYXI 6.92 (-21.98%) Well, that was short-lived. Maybe it was the buyback
👍️0
rado rado 2 years ago
Where do you hear that? I haven't heard that.
👍️0
rado rado 2 years ago
ZYXI (9.00 +18%) is having a good day today
👍️0
rado rado 2 years ago
ZYXI (9.00 +18%) is having a good day today
👍️0
penn33c penn33c 2 years ago
Im sending myself a note $8.10 is a nice close Friday
👍️0
penn33c penn33c 2 years ago
Looks like we are going higher from here What does everyone else think?
👍️0
penn33c penn33c 2 years ago
things to seem to be going well!!!! Going private?
👍️0
penn33c penn33c 2 years ago
What would happen to us >If they go private?
👍️0
penn33c penn33c 2 years ago
Anyone ever hear anything on company going private? I keep hearing some noise about it.?
👍️0
MysticChaCha MysticChaCha 2 years ago
My gut feeling for Zynex is that there is good news from this point onward. This company is expanding. The stock market in general is bullish, otherwise why is Warren Buffett on a buying spree. I think things for Zynex are good from here.
👍️0
penn33c penn33c 2 years ago
10 million dollar buyback This is looking great
👍️0
penn33c penn33c 2 years ago
Is anyone hearing rumors that Zynex is going private?
👍️0
penn33c penn33c 2 years ago
Twitter is anyone on that?

Friends tell me there talking about Zynex going Private

How bad would that hurt the shorts?

And what would be the price if that happened? My guess would be 25 bucks

👍️0
penn33c penn33c 2 years ago
Anyone seen any info on ZYNEX going private? I had a friend of mine ask me about it!!!
👍️0
penn33c penn33c 2 years ago
Simply Wall Street had a nice article today I found it on Yahoo Finance
👍️0
MysticChaCha MysticChaCha 2 years ago
UFO was right several months ago about Zynex retracing back around the $6.30 range.
👍️0
MysticChaCha MysticChaCha 2 years ago
I hope the Zynex uptrend continues too. I see a lot of news for Zynex expanding its facilities and its products.
👍️0

Your Recent History

Delayed Upgrade Clock